Diabetes Research Centers

The Lazar laboratory is studying the transcriptional regulation of metabolism. We are particularly focused on the role played by nuclear receptors.
The Penn Diabetes Research Center participates in the nationwide inter-disciplinary program established over forty years ago by the NIDDK to foster research and training in the areas of diabetes and related endocrine and metabolic disorders.
Dr. Myers’ research focuses on the processes that enable the body to respond normally to insulin, and how problems in these pathways contribute to the development of insulin resistance and diabetes.
The goal of the Michigan Diabetes Research Center (MDRC) is to establish, promote, and enhance multidisciplinary and collaborative basic biomedical and clinical research among member investigators studying diabetes, its complications, and related endocrine and metabolic disorders.
The Garvey laboratory is interested in the molecular, metabolic, and genetic basis of type 2 diabetes mellitus, insulin resistance, and obesity.
The Diabetes Research and Training Center (DRC) focuses on developing new methods to treat, prevent, and ultimately cure diabetes and its complications.
Dr. Bell’s research focuses on the genetics of diabetes mellitus. Ongoing studies in his laboratory include the genetics of type 2 diabetes in the Mexican American population of Starr County, Texas.
The University of Chicago Diabetes Research and Training Center (DRTC) provides resources for the support and coordination of the research and training activities in diabetes and related metabolic and endocrine disorders of a large and growing number of independently funded but highly interactive investigators.
Dr. Alan Saltiel investigates the hormone insulin and its role in regulating cellular sugar levels, including how cells send and receive signals. Understanding these processes may shed light on dysfunctioning glucose and lipid metabolism, particularly as it related to Type 2 diabetes.
The overall mission of the UCSD-UCLA DRC is to foster research in theprevention and treatment of diabetes and its complications, and to improve the lives of patients suffering from this devastating disease.
The goals of Dr. Evans-Molina’s research program are (1) to define the molecular and inflammatory etiologies of b cell dysfunction in Type 1 and Type 2 diabetes and (2) to identify novel stem cell based strategies to improve b cell survival in diabetes.
The Center for Diabetes and Metabolic Diseases (CDMD) at IU School of Medicine is a world-renowned center focused on centralizing and fostering research along five fundamental themes to strengthen the diabetes research base throughout Indiana.
My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms.
The Yale Diabetes Research Center (DRC) was established in the spring of 1993 with the goal of promoting research in diabetes and related metabolic and endocrine disorders at the university.
Dr. German is the Associate Director and Clinical Director of the UCSF Diabetes Center, Director of the the Hillblom Islet Genesis Network and the UCSF NIH Diabetes Research Center (DRC).
The University of California San Francisco Diabetes Research Center (UCSF DRC) is one of only 16 research centers established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to accelerate basic and clinical research into diabetes.
Dr. Kahn received his medical degree from the University of Cape Town, South Africa. He is an endocrinologist whose research focuses on the mechanisms responsible for the critical impairments in insulin secretion that result in the development of diabetes.
The University of Washington (UW) Diabetes Research Center (DRC) at the University of Washington is one of 16 Diabetes Research Centers sponsored by the National Institutes of Health to promote basic, translational, and clinical research on diabetes and related metabolic disorders.
My laboratory studies the mechanism by which hyperglycemia and insulin resistance are causing diabetic retinopathy, nephropathy and cardiovascular diseases.
Since its inception in 1898, the primary mission of the Joslin Diabetes Center has been to care for people with diabetes, and conduct research to provide new knowledge about diabetes and its complications that will lead to new treatments, prevention and/or cure of these disorders.
Diabetes Centers

NIDDK Diabetes Centers

The NIDDK-supported Diabetes Research Centers (DRCs) are part of an integrated program of diabetes and related endocrinology and metabolism research. NIDDK’s Diabetes Centers program supports extramural research institutions that have established an existing base of high-quality, diabetes-related research. Centers provide increased, cost effective collaboration among multidisciplinary groups of investigators at institutions with an established, comprehensive research base in diabetes and related areas of endocrinology and metabolism. DRCs are intended to improve the quality and multidisciplinary nature of research on diabetes by providing shared access to specialized technical resources and expertise. DRCs are intended to facilitate progress in research with the goal of developing new methods to treat, prevent and ultimately cure diabetes mellitus and its complications.